483 related articles for article (PubMed ID: 25228659)
1. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.
Shinbrot E; Henninger EE; Weinhold N; Covington KR; Göksenin AY; Schultz N; Chao H; Doddapaneni H; Muzny DM; Gibbs RA; Sander C; Pursell ZF; Wheeler DA
Genome Res; 2014 Nov; 24(11):1740-50. PubMed ID: 25228659
[TBL] [Abstract][Full Text] [Related]
2. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP
Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559
[TBL] [Abstract][Full Text] [Related]
3. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.
Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH
PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
Soriano I; Vazquez E; De Leon N; Bertrand S; Heitzer E; Toumazou S; Bo Z; Palles C; Pai CC; Humphrey TC; Tomlinson I; Cotterill S; Kearsey SE
PLoS Genet; 2021 Jul; 17(7):e1009526. PubMed ID: 34228709
[TBL] [Abstract][Full Text] [Related]
5. POLE/POLD1 mutation and tumor immunotherapy.
Ma X; Dong L; Liu X; Ou K; Yang L
J Exp Clin Cancer Res; 2022 Jul; 41(1):216. PubMed ID: 35780178
[TBL] [Abstract][Full Text] [Related]
6. Characterization of POLE c.1373A > T p.(Tyr458Phe), causing high cancer risk.
Rocque MJ; Leipart V; Kumar Singh A; Mur P; Olsen MF; Engebretsen LF; Martin-Ramos E; Aligué R; Sætrom P; Valle L; Drabløs F; Otterlei M; Sjursen W
Mol Genet Genomics; 2023 May; 298(3):555-566. PubMed ID: 36856825
[TBL] [Abstract][Full Text] [Related]
7. Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
Huang F; Tanaka H; Knudsen BS; Rutgers JK
BMC Med Genet; 2020 Aug; 21(1):167. PubMed ID: 32838755
[TBL] [Abstract][Full Text] [Related]
8. Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer.
Yoshida R; Miyashita K; Inoue M; Shimamoto A; Yan Z; Egashira A; Oki E; Kakeji Y; Oda S; Maehara Y
Eur J Hum Genet; 2011 Mar; 19(3):320-5. PubMed ID: 21157497
[TBL] [Abstract][Full Text] [Related]
9. The evolving tale of Pol2 function.
Gallitto M; Zhang Z
Genes Dev; 2023 Feb; 37(3-4):72-73. PubMed ID: 36813532
[TBL] [Abstract][Full Text] [Related]
10. Balancing act of a leading strand DNA polymerase-specific domain and its exonuclease domain promotes genome-wide sister replication fork symmetry.
Meng X; Claussin C; Regan-Mochrie G; Whitehouse I; Zhao X
Genes Dev; 2023 Feb; 37(3-4):74-79. PubMed ID: 36702483
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair and DNA polymerase δ proofreading prevent catastrophic accumulation of leading strand errors in cells expressing a cancer-associated DNA polymerase ϵ variant.
Bulock CR; Xing X; Shcherbakova PV
Nucleic Acids Res; 2020 Sep; 48(16):9124-9134. PubMed ID: 32756902
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint-mediated DNA polymerase ε exonuclease activity curbing counteracts resection-driven fork collapse.
Pellicanò G; Al Mamun M; Jurado-Santiago D; Villa-Hernández S; Yin X; Giannattasio M; Lanz MC; Smolka MB; Yeeles J; Shirahige K; García-Díaz M; Bermejo R
Mol Cell; 2021 Jul; 81(13):2778-2792.e4. PubMed ID: 33932350
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of Cancer-Associated DNA Polymerase ε Variants in
Barbari SR; Kane DP; Moore EA; Shcherbakova PV
G3 (Bethesda); 2018 Mar; 8(3):1019-1029. PubMed ID: 29352080
[TBL] [Abstract][Full Text] [Related]
14. Germline PMS2 and somatic POLE exonuclease mutations cause hypermutability of the leading DNA strand in biallelic mismatch repair deficiency syndrome brain tumours.
Andrianova MA; Chetan GK; Sibin MK; Mckee T; Merkler D; Narasinga RK; Ribaux P; Blouin JL; Makrythanasis P; Seplyarskiy VB; Antonarakis SE; Nikolaev SI
J Pathol; 2017 Nov; 243(3):331-341. PubMed ID: 28805995
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
Palles C; Cazier JB; Howarth KM; Domingo E; Jones AM; Broderick P; Kemp Z; Spain SL; Guarino E; Salguero I; Sherborne A; Chubb D; Carvajal-Carmona LG; Ma Y; Kaur K; Dobbins S; Barclay E; Gorman M; Martin L; Kovac MB; Humphray S; ; ; Lucassen A; Holmes CC; Bentley D; Donnelly P; Taylor J; Petridis C; Roylance R; Sawyer EJ; Kerr DJ; Clark S; Grimes J; Kearsey SE; Thomas HJ; McVean G; Houlston RS; Tomlinson I
Nat Genet; 2013 Feb; 45(2):136-44. PubMed ID: 23263490
[TBL] [Abstract][Full Text] [Related]
16. Human Pol ε-dependent replication errors and the influence of mismatch repair on their correction.
Agbor AA; Göksenin AY; LeCompte KG; Hans SH; Pursell ZF
DNA Repair (Amst); 2013 Nov; 12(11):954-63. PubMed ID: 24051051
[TBL] [Abstract][Full Text] [Related]
17. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.
Albertson TM; Ogawa M; Bugni JM; Hays LE; Chen Y; Wang Y; Treuting PM; Heddle JA; Goldsby RE; Preston BD
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17101-4. PubMed ID: 19805137
[TBL] [Abstract][Full Text] [Related]
18. The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
Poulos RC; Olivier J; Wong JWH
Nucleic Acids Res; 2017 Jul; 45(13):7786-7795. PubMed ID: 28531315
[TBL] [Abstract][Full Text] [Related]
19. POLE somatic mutations in advanced colorectal cancer.
Guerra J; Pinto C; Pinto D; Pinheiro M; Silva R; Peixoto A; Rocha P; Veiga I; Santos C; Santos R; Cabreira V; Lopes P; Henrique R; Teixeira MR
Cancer Med; 2017 Dec; 6(12):2966-2971. PubMed ID: 29072370
[TBL] [Abstract][Full Text] [Related]
20. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.
Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F
Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
